Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Decoding Human Placental Cellular and Molecular Responses to Obesity and Fetal Growth

Jiang H., Derisoud E., Parreira D., Taebnia N., Jannig PR., Shafagh RZ.

Laboratory Study on Chronic Inflammation, published in Adv Sci (Weinh) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Adv Sci (Weinh) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41560306
PMCID
PMC13042494
DOI
10.1002/advs.202509691
Citations
2

Abstract (original English)

Maternal obesity increases the risks of large-for-gestational-age (LGA) births and subsequent cardiometabolic disorders in offspring. To identify placental signatures associated with these outcomes, we performed single-nucleus RNA sequencing on placentas from women with obesity delivering appropriate-for-gestational-age or LGA infants, compared to normal-weight controls. In maternal obesity, regardless of fetal growth, syncytiotrophoblasts showed upregulated hypoxia and TNF-α signaling, while cytotrophoblasts exhibited downregulated receptor tyrosine kinase signaling. However, villous non-trophoblasts displayed upregulated TNF-α signaling and inflammatory responses only in LGA placentas. Notably, Hofbauer cells in LGA placentas presented transcriptional alterations in immunometabolism-related genes and displayed elevated SPP1 expression, which potentially acts as a ligand for other placental cell types. We modeled key aspects of syncytiotrophoblast responses to adipose tissue using a customized microfluidic organoids-on-a-chip co-culture system. These findings revealed gene expression patterns of placental cells to maternal obesity that are shared or different between O-A and O-L, highlighting pathways for future mechanistic investigation.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
TrophoblastsPlacentaHumansObesityFetal DevelopmentPregnancyAdultFemaleInfant, Large for Gestational AgePregnancy in Obesity

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research